Table 1.

Patient characteristic

Subject	Age	Gender	HR	Clinical features	Medications
NSTEMI	49	male	65	Hypertension, hyperlipidemia	ASA, Clopidogrel, betablocker, statin, calcium antagonist
NSTEMI	53	male	70	Smoker, hypertension, hyperlipidemia	ASA, ACE1, Clopidogrel, betablocker, statin, calcium antagonist, diuretics
NSTEMI	55	female	63	Smoker, psoriasis	ASA, Clopidogrel, betablocker, statin
NSTEMI	56	male	61	Smoker	ASA, Clopidogrel, betablocker, statin
NSTEMI	60	male	59	Renal failure	ASA, Clopidogrel, statin,
NSTEMI	63	male	56	Smoker, hypertension	ASA, Clopidogrel, betablocker, statin, ACE-inhibitor,
NSTEMI	72	male	53	Diabetes II	ASA, Clopidogrel, betablocker, statin, ACE-inhibitor, Metforminen, Glibenclamide
Control	49	male	60	Ex-smoker, hypertension, diabetes II	ASA, ACE1, betablocker, calcium antagonist, metformine
Control	52	male	59	Myeloma	Talidomide, steroids, ASA
Control	54	female	57	Diabetes II, Bypass 2004	Statin, betablocker, calcium antagonist, metformine
Control	59	male	71	Hypertension, liver cirrosis	-
Control	62	male	66	Ex-smoker, hypothyreosis	Levaxine
Control	62	male	70	Atrial fibrillation	Betablocker
Control	73	male	54	-	-

Patient characteristic for the NSTEMI group and their matched controls.